Pulmonary Alveolar Microlithiasis: A Review of a Rare Disease Through Rarely Discussed Perspectives
Seminars in Respiratory and Critical Care Medicine · 2026-08 · 47 (04) · 396-408
DOI: 10.1055/a-2716-4930 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, online erschienen am 29.10.2025. Verfasst von Göksel Altınışık und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Diseases, Faculty of Medicine, Pamukkale University, Denizli, Türkiye. Hauptthemen laut MEDLINE: Lung Diseases, Sodium-Phosphate Cotransporter Proteins, Type IIb, Rare Diseases, Calcinosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Pulmonary alveolar microlithiasis (PAM) has been well characterized in terms of its description, genetic background, and diagnostic process for decades; however, no effective prevention or treatment has yet been established. PAM is classified as an ultrarare lung disease linked to mutations in the autosomal recessive sodium–phosphate co-transporter gene SLC34A2, which may serve as a potential target for future therapies. As new variants of SLC34A2 mutations continue to be identified, a broader genetic understanding could help predict the variable clinical course among patients and guide the development of therapies beyond palliative care. The creation of a disease severity score would be valuable for assessing disease burden, stratifying patients, and designing research studies. Given the clinico-radiological dissociation and heterogeneity of PAM, such a score should be developed as a composite index. Coupled with objective severity measures and identification of factors underlying individual variability, this approach could enhance insight into preventive and therapeutic strategies. Clinical advances in PAM remain limited, underscoring the need for international registries and cohorts as an urgent priority. Systematic re-evaluation of diagnosed cases and structured follow-up, rather than arbitrary visits, would generate standardized data critical for future research. A standardized patient evaluation form may facilitate the collection of data in a shared database.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chest Diseases, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.
- Department of Chest Diseases, Afyonkarahisar State Hospital, Afyonkarahisar, Türkiye.
ORCID-Profile: Göksel Altınışık, Nilüfer Yiğit, Nazlı Çetin
Zitieren
APA
Altınışık, G., Yiğit, N., & Çetin, N. (2026). Pulmonary Alveolar Microlithiasis: A Review of a Rare Disease Through Rarely Discussed Perspectives. Seminars in Respiratory and Critical Care Medicine, 47(04), 396-408. https://doi.org/10.1055/a-2716-4930
Vancouver
Altınışık G, Yiğit N, Çetin N. Pulmonary Alveolar Microlithiasis: A Review of a Rare Disease Through Rarely Discussed Perspectives. Seminars in Respiratory and Critical Care Medicine. 2026;47(04):396-408. doi:10.1055/a-2716-4930
BibTeX
@article{Altnk2026,
author = {Altınışık, Göksel and Yiğit, Nilüfer and Çetin, Nazlı},
title = {Pulmonary Alveolar Microlithiasis: A Review of a Rare Disease Through Rarely Discussed Perspectives},
journal = {Seminars in Respiratory and Critical Care Medicine},
year = {2026},
volume = {47},
number = {04},
pages = {396--408},
doi = {10.1055/a-2716-4930}
}
EUVIMED